FLT3 (CD135) expression in pediatric AML is associated with distinct features and worse outcomes with sorafenib therapy

Blood Neoplasia · Elsevier

Аннотация

Publication date: August 2026 Source: Blood Neoplasia, Volume 3, Issue 3 Author(s): Andrew J. Menssen, Amenech B. Ashango, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Fan-Chi Hsu, Loren L. Lott, Fangyan Dai, Todd M. Cooper, Jessica A. Pollard, Katherine Tarlock, Richard Aplenc, Soheil Meshinchi, Lisa Eidenschink Brodersen, Denise A. Wells, Michael R. Loken, Chad A. Hudson

Читать у издателя →

Похожие статьи